• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

CID 16020046

CAS No. 834903-43-4

CID 16020046 ( CID16020046; CID-16020046 )

产品货号. M19158 CAS No. 834903-43-4

CID16020046 is a selective GPR55 antagonist, inhibiting GPR55 constitutive activity with IC50 of 0.15 μM in yeast.

纯度: 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥454 有现货
5MG ¥745 有现货
10MG ¥1175 有现货
25MG ¥1993 有现货
50MG ¥2940 有现货
100MG ¥4366 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    CID 16020046
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    CID16020046 is a selective GPR55 antagonist, inhibiting GPR55 constitutive activity with IC50 of 0.15 μM in yeast.
  • 产品描述
    CID16020046 is a selective GPR55 inverse agonist. CID16020046 is a G protein-coupled receptor that is weakly activated by some cannabinoids at nM concentrations. CID16020046 has been shown to block GPR55-mediated endothelial wound healing and reverse LPI-inhibited platelet aggregation.
  • 同义词
    CID16020046; CID-16020046
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    GPR55
  • 研究领域
    Others-Field
  • 适应症
    ——

化学信息

  • CAS Number
    834903-43-4
  • 分子量
    425.44
  • 分子式
    C25H19N3O4
  • 纯度
    98%
  • 溶解度
    DMSO : ≥ 28 mg/mL; 65.81 mM
  • SMILES
    CC1=CC=C(C=C1)C2=NNC3=C2C(N(C3=O)C4=CC=C(C=C4)C(=O)O)C5=CC(=CC=C5)O
  • 化学全称
    4-[4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1,4-dihydropyrrolo[3,4-d]pyrazol-5-yl]benzoic acid

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Kargl J, et al. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function. J Pharmacol Exp Ther. 2013 Jul;346(1):54-66.
产品手册
关联产品
  • Ilexoside D

    Ilexoside D has ant-allergic, and anti-coagulant activities, it shows anti-tissue factor activity as well as the antithrombotic activity.

  • Brivaracetam

    Brivaracetam in vitro exerts a dose-dependent cytotoxic effect on various glioma cell lines and this effect is concomitant with the modulation of a number of miRNAs.

  • Fmoc-Thr(GlcNAc(Ac)3...

    This amino acid is compatible with standard protocols in Fmoc solid phase peptide synthesis.